BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Eli Lilly and Company’s Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients With Type 2 Diabetes

  June 24, 2013

   · 

  7 min read
• BioCapital

  Seegene, Inc. to Feature Extended Mutation Detection Technology for Companion Diagnostics at American Association for Clinical Chemistry 2013

  June 24, 2013

   · 

  2 min read
• CeQur SA Release: New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People With Type 2 Diabetes

  June 24, 2013

   · 

  4 min read
• Business

  Greenphire and Oracle Work Together to Automate Clinical Trial Planning, Budgeting and Payments

  June 24, 2013

   · 

  3 min read
• Drug Development

  Isis Pharmaceuticals, Inc. Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions in Triglycerides and APOC-III in Patients With High Triglycerides and Type 2 Diabetes

  June 24, 2013

   · 

  7 min read
• Bio NC

  INC Research, Inc. Becomes First CRO to Achieve Accreditations Across Entire Medidata Clinical Cloud

  June 24, 2013

   · 

  4 min read
• Biotech Beach

  Sorrento Therapeutics, Inc. Presents Preclinical Data of its Fully Human Antibody Programs Targeting Anti-PD-L1 and Anti-PD-1 at the 8th Annual Next Generation Protein Therapeutics Summit

  June 24, 2013

   · 

  3 min read
• Drug Development

  Affimed Therapeutics AG Reports Phase 1 Clinical Data for Its Immunotherapy AFM13 in Relapsing/Refractory Hodgkin Lymphoma Patients

  June 24, 2013

   · 

  5 min read
• Drug Development

  Lexicon Pharmaceuticals, Inc. Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211

  June 24, 2013

   · 

  4 min read
• Genetown

  PAREXEL International Launches New Functional Services Unit

  June 24, 2013

   · 

  5 min read